Regarding "Altered fibrin clot structure and function in individuals with intermittent claudication"

Journal of Vascular Surgery

Volumn 49, Issue 4, 2009, Pages 1088-1089

  Bhasin, Neeraj ^a   Parry, Duncan J ^a   Scott, D Julian A ^a   Ariëns, Robert A S ^a   Grant, Peter J ^a   West, Robert M ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13; CARDIOVASCULAR AGENT; FIBRIN;

ARTERY DISEASE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CORONARY HEMODYNAMICS; DIABETES MELLITUS; DISEASE COURSE; EX VIVO STUDY; FAMILY HISTORY; FIBRIN CLOT; FIBRINOLYSIS; HEART INFARCTION; HUMAN; INTERMITTENT CLAUDICATION; LASER MICROSCOPY; LETTER; MORTALITY; PRIORITY JOURNAL; RELATIVE; TURBIDITY;

BLOOD COAGULATION; CARDIOVASCULAR DISEASES; FAMILY; FIBRIN; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERMITTENT CLAUDICATION; PEDIGREE; PERIPHERAL VASCULAR DISEASES; PROGNOSIS; RISK FACTORS;

EID: 63249132851     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.11.028     Document Type: Letter

References (6)

1. Bhasin N, Ariëns RAS, West RM, Parry DJ, Grant PJ, Scott DJA. Altered fibrin clot structure and function in the healthy first degree relatives of subjects with intermittent claudication. J Vasc Surg Article [Epub ahead of print].
2. Fatah K., Silveira A., Tornvall P., Karpe F., Blomback M., and Hamsten A. Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age. Thromb Haemost 76 (1996) 535-540
3. Nair C.H., Azhar A., and Dhall D.P. Studies of fibrin network structure in human plasma. Part II: Clinical application-Diabetes and Antidiabetic drugs. Thromb Res 64 (1991) 477-485
4. Undas A., Celinska-Löwenhoff M., Löwenhoff T., and Szczeklik A. Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease. J Thromb Haemost 4 (2006) 1029-1036
5. Williams S., Fatah K., Hjemdahl P., and Blomback M. Better increase in fibrin gel porosity by low dose than intermediate dose acetylsalicylic acid. Eur Heart J 19 (1998) 1666-1672
6. Criqui M.H., Langer R.D., Fronek A., Feigelson H.S., Klauber M.R., McCann T.J., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326 (1992) 381-386